Lys9 for Glu9 substitution in glucagon-like peptide-1(7-36)amide confers dipeptidylpeptidase IV resistance with cellular and metabolic actions similar to those of established antagonists glucagon-like peptide-1(9-36)amide and exendin (9-39).


Autoria(s): Green, Brian
Data(s)

01/02/2004

Identificador

http://pure.qub.ac.uk/portal/en/publications/lys9-for-glu9-substitution-in-glucagonlike-peptide1736amide-confers-dipeptidylpeptidase-iv-resistance-with-cellular-and-metabolic-actions-similar-to-those-of-established-antagonists-glucagonlike-peptide1936amide-and-exendin-939(075ffc94-37c3-4b66-966f-620fd289678f).html

http://www.scopus.com/inward/record.url?scp=0842284596&partnerID=8YFLogxK

Idioma(s)

eng

Direitos

info:eu-repo/semantics/restrictedAccess

Fonte

Green , B 2004 , ' Lys9 for Glu9 substitution in glucagon-like peptide-1(7-36)amide confers dipeptidylpeptidase IV resistance with cellular and metabolic actions similar to those of established antagonists glucagon-like peptide-1(9-36)amide and exendin (9-39). ' Metabolism , vol 53(2) , no. 2 , pp. 252-259 .

Palavras-Chave #/dk/atira/pure/subjectarea/asjc/1300/1310 #Endocrinology #/dk/atira/pure/subjectarea/asjc/2700/2712 #Endocrinology, Diabetes and Metabolism
Tipo

article